Benzoxazinone-derived compounds, their preparation and use...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S092000

Reexamination Certificate

active

07056914

ABSTRACT:
The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.

REFERENCES:
patent: WO 95/02405 (1995-01-01), None
patent: WO 95/28397 (1995-10-01), None
patent: WO 97/19682 (1997-06-01), None
patent: WO 97/20823 (1997-06-01), None
patent: WO 97/25992 (1997-07-01), None
patent: WO 97/38665 (1997-10-01), None
patent: WO 98/24768 (1998-06-01), None
patent: WO 98/35957 (1998-08-01), None
patent: WO 98/40356 (1998-09-01), None
patent: WO 99/40091 (1999-08-01), None
patent: WO 00/20376 (2000-04-01), None
patent: WO 01/07409 (2001-02-01), None
patent: WO 01/13917 (2001-03-01), None
patent: WO 01/44213 (2001-06-01), None
patent: WO 01/64675 (2001-09-01), None
patent: WO 02/094825 (2002-11-01), None
Hackh's Chemical Dictionary (Fourth Edition) 1969, pp. 25 and 193.
http://www.encyclopedia.com/html/a1/aliphati.asp downloaded on Apr. 6, 2005.
William, et al. “1-{1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperdin-4-yl}-4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Oxytocin Antagonist”, J. Med. Chem., 1995, 38, pp. 4634-4636.
Williams, et al., “Nonpeptide Oxytocin Antagonists: Analogs of L-371,257 with Improved Potency”, Bioorganic & Medicinal Chemistry Letters, 9, (1999), pp. 1311-1316.
“Multiple Receptors For Neuropeptide Y In The Hippocampus: Putative Roles In Seizures And Cognition”, Redrobe et al., Brain Research Interactive, 848, 1999.
“Neuropeptide Y: A Possible Role In Hypertension?”, Michel et al., Journal of Hypertension 1995.
“Identification Of A Novel Hypothalamic Neuropeptide Y Receptor Associated With Feeding Behavior”, Hu et al., Journal of Biological Chemistry, vol. 271, No. 42, 1996.
“A Receptor Subtype Involved In Neuropeptide-Y-Induced Food Intake”, Gerald, et al., Letters to Nature, vol. 382, 1996.
“1-{1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Ozytocin Antagonist”, Williams et al., Jnl. Med. Chem., 38, 1995.
“Autoradiographic Reevaluation Of The Binding Properties Of125I-[Leu31,Pro34]Peptide YY and125I-Peptide YY3-36to Neuropeptide Y Receptor Subtypes In Rat Forebrain”, Gobbi et al., Journal of Neurochemistry, 1999.
“Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines”, Bell et al., J. Med. Chem., 41, 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzoxazinone-derived compounds, their preparation and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzoxazinone-derived compounds, their preparation and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazinone-derived compounds, their preparation and use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3678910

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.